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General Information and Protocols 
 
Safety Statement. All chemical transformations were performed in a well-ventilated fume 
hood to avoid inhalation and exposure. For protein concentration determination experiments, 
carbon monoxide (CO) is used. CO is flammable, highly toxic, and can be lethal at high doses and 
must be used in a fume hood equipped with a CO detector to avoid accidental exposure. Other than 
that, no unexpected or unusually high safety concerns were raised with these methods. Safety notes 
for individual synthetic procedures will be documented alongside the procedure. 
 
General Information. All chemical transformations were performed in a well-ventilated fume 
hood to avoid inhalation and exposure to chemicals. Reagents and solvents were obtained 
commercially (Sigma-Aldrich, Alfa Aesar, VWR, Fischer, Matrix Scientific, Oakwood Chemical, 
TCI America, and other suppliers) and used without prior purification unless otherwise stated. 
Organic solutions were concentrated under reduced pressure on an IKA RV 10 rotary evaporator. 
Thin-layer chromatography (TLC) was performed on commercial Millipore Silica Gel 60 plates 
containing the F254 fluorescent indicator. Visualization of the developed chromatographs was 
performed by irradiation with UV light, or treating with and appropriate TLC staining solution 
(e.g., Ceric Ammonium Molybdate, KMnO4, or Bromocresol Green) followed by heating if 
necessary. Chromatographic purification was accomplished by flash chromatography on Silacycle 
F60 silica gel according to the method of Still1 or using a Biotage Isolera One instrument.  
 
Spectral Data. All NMR spectra were obtained at the Caltech Liquid NMR Facility. For 
azetidine products, 1H and 13C NMR were recorded on a Bruker Prodigy 400 MHz instrument (400 
MHz and 101 MHz). 19F NMR spectra were recorded on a Varian 300 MHz spectrometer (282 
MHz). For intermediates, 1H spectra were also recorded using a Varian 300 MHz spectrometer 
(300 MHz), a Varian 500 MHz spectrometer (500 MHz), and a Varian 600 MHz spectrometer 
(600 MHz). 1H and 13C spectra are referred to residual CDCl3 solvent signals referenced at δ 7.26 
and 77.0 ppm, respectively. For spectra taken in DMSO, the residual 1H and 13C solvent signals 
are referenced at δ 2.50 and 39.51 ppm, respectively. 19F spectra are referenced by addition of the 
appropriate internal reference standard, using either fluorobenzene (referenced at δ –113.15 ppm) 
or hexafluorobenzene (referenced at δ –161.90) and are clearly labeled when shown. Data for 1H 
NMR are reported as follows: chemical shift (δ ppm), integration, multiplicity (s = singlet, d = 
doublet, t = triplet, q = quartet, p = pentad, sext = sextet, hept = heptet, m = multiplet, br s = broad 
singlet), and coupling constant (Hz). Data for 13C NMR are reported in terms of chemical shift, 
multiplicity, and coupling constant: no special nomenclature is used for equivalent carbons. Data 
for 19F NMR are reported in terms of chemical shift, multiplicity, and coupling constant. High-
resolution mass spectra (HRMS) were obtained at Caltech Mass Spectrometry Facility. 
 
Gas Chromatography Data. GC chromatography (GC) was performed on an Agilent 
Technologies 7892A GC system equipped with a split-mode capillary injection system and flame-
ionization detectors. For achiral analyses, an Agilent J&W HP-5 Column was used as the 
stationary phase. For chiral analyses, the specific stationary phase is provided along with the chiral 
traces. 
 
Cloning, Site-Saturation Mutagenesis (SSM), and Plasmid Isolation. Electrocompetent 
Escherichia coli (E. coli) cells were prepared following the protocol of Sambrook and Russell.2 
S2 
Phusion polymerase and DpnI were purchased from New England Biolabs (NEB, Ipswich, MA). 
SSM experiments were performed using primers bearing degenerate codons (NDT, VHG, TGG) 
as per the”22 codon trick” using a modified QuikChange™ protocol.3 The PCR conditions were 
as follows (final concentrations): Phusion HF Buffer 1x, 0.2 mM dNTPs each, 0.5 μM of forward 
primers, 0.5 μM reverse primer, and 0.02 U/μL of Phusion polymerase. Upon completion of PCRs, 
the remaining template was digested with DpnI. Gel purification was performed with a Zymoclean 
Gel DNA Recovery Kit (Zymo Research Corp, Irvine, CA). The purified PCR product was then 
assembled using the Gibson assembly protocol.4  
 
Transformation of Genes and Plasmid Isolation. The assembly products obtained were used 
to transform electrocompetent E. cloni® EXPRESS BL21(DE3) cells (Lucigen, Middleton, WI) 
with a MicroPulser Electroporator (Bio-Rad, Hercules, CA). Luria-Bertani medium (LB; 0.6 mL) 
was added to electroporated cells and they were incubated at 37 ºC with shaking at 220 rpm for 45 
minutes before being plated on LB agar plates with 100 μg/mL ampicillin (LB-amp agar plates). 
Plates were incubated at 37 ºC overnight. Single colonies from these plates were used to inoculate 
flask cultures, prepare glycerol stocks, and isolate plasmids for sequencing. Plasmids were isolated 
using a QIAprep Spin Miniprep Kit (Qiagen, Hilden, Germany), and the genes were sequence-
verified (Laragen, Inc.). 
 
96-Well Plate Library Expression. 96-well deep-well plates are shaken in an INFORS HT 
Multitron Shaker in all instances. Single colonies from LB-agar plates were picked using sterilized 
toothpicks, which were used to inoculate 400 μL of LB containing 100 μg/mL of ampicillin (LB-
amp) in 2mL 96-well deep-well plates. The plates are incubated at 37 ºC and 220 rpm overnight. 
For expression cultures, 50 μL of these precultures are used to inoculate 900 μL of Hyperbroth 
(AthenaES) with 100 μg/mL of ampicillin (HB-amp) per well in 96-well deep-well plates. The 
remaining overnight culture plates are sealed are stored in a 4 ºC refrigerator until needed 
again.The expression cultures are initial incubated at 37 ºC and 220 rpm for 2.5 hours, at which 
point they are allowed to chill on ice for 45 minutes. Expression of proteins was induced with 
isopropyl-β-D-thiogalactoside (IPTG) and cellular heme production was increased with 5-
aminolevulinic acid (ALA). An induction mixture containing IPTG and ALA in HB-amp (50 μL) 
was added to each well such that the final concentrations of IPTG and ALA were 0.5 mM and 1.0 
mM respectively. The total culture volumes were 1 mL. The plates were then incubated at 22 ºC 
and 200 rpm overnight. 
 
96-Well Plate Library Reactions and Screening. Expression cultures containing E. coli 
expressing hemoproteins of interest were centrifuged at 5000 × g for 5 minutes at 4 ºC. The 
supernatant was discarded, and nitrogen-free M9 minimal media (M9-N, 380 μL) was added to 
each well. The plates were then put into a vinyl Coy anaerobic chamber (0 – 30 ppm O2) and the 
pellets are resuspended. To each well were added 20 μL of a MeCN solution with 200 mM of the 
desired aziridine substrate and 300 mM of ethyl diazoacetate (EDA). The final reaction volume 
was 400 μL, and the final concentrations of the desired aziridine and EDA were 10 mM and 15 
mM, respectively. The plates were then sealed carefully with a foil cover, removed from the Coy 
chamber, and shaken at room temperature for 16 hours. Once complete, plates were worked up for 
processing by adding 600 μL of a 1:1 solution of ethyl acetate:cyclohexane with 1,3,5-
trimethoxybenzene as an internal standard (10 mM concentration). A silicone sealing mat 
(AWSM1003S, ArcticWhite) was used to cover the plate, and the two layers were thoroughly 
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mixed. The plate was then centrifuged (5000 × g for 5 minutes at room temperature) to separate 
the phases. Afterwards, an aliquot of the organic layer was transferred to a GC vial insert in a GC 
vial and the samples were assayed by GC.  
If wells were identified which showed improved activity over control wells containing the 
parent variant, these were subjected to sequence identification and validation of activity. The 
corresponding wells in the overnight culture plate were streaked out on an LB-Amp plate along 
with a single streakout of a parent control well. Single colonies from these plates were then 
subjected to the small-scale protein expression conditions below, followed by the small-scale 
biocatalytic reaction protocol described below. 
 
Small-Scale Protein Expression. Single colonies from LB-Agar plates were picked using a 
sterile pipette tip and were used to inoculate 6 mL of LB-amp in a 15 mL plastic culture tube. 
Cultures are incubated at 37 ºC with shaking at 220 rpm overnight in an Innova 4000 incubator. 
Two mL of these overnight cultures were used to inoculate 100 mL of HB-amp (1% v/v starter 
culture in expression culture) in 250-mL Erlenmeyer flasks. The remainder of the overnight culture 
was subjected to sequence identification (for new variants) and verification (for parent control 
wells). The expression cultures were incubated at 37 ºC and 220 rpm for 2.5 hours in an Innova 42 
shaker, at which point they were held on ice for 45 minutes. Protein expression was then induced 
by direct addition of 100 μL of stock solutions containing 500 mM IPTG and 1.0 mM ALA such 
that the final concentrations were 0.5 mM and 1.0 mM, respectively. The cultures were shaken at 
22 ºC and 140 rpm for 16 hours in an Innova 42 shaker. 
 
Small-Scale Biocatalytic Reactions for Lineage Validation. The corresponding 100 mL 
expression cultures were pelleted (5000 × g for 5 minutes at 4 ºC) and resuspended in 6 mL of M9-
N buffer. The protein concentration of this sample was determined by CO binding (vide infra), and 
380 μL portions of whole cell suspension (WCS) were prepared in GC vials such that the protein 
concentration is 5.25 μM. The whole cell suspensions were put into a vinyl Coy anaerobic 
chamber, at which point 10 μL of a 400 mM solution of aziridine in MeCN followed by 10 μL of 
a 600 mM solution of EDA in MeCN were added such that the final reaction concentrations were 
5.0 μM of the protein variant, 10 mM of the desired aziridine, and 15 mM of EDA. The GC vials 
were tightly capped with screwcaps with a septum, were brought out of the Coy chamber, and 
were allowed to shake at RT for 16 hours. Once complete, the reactions were transferred to a 1.7 
mL Eppendorf tube and 600 μL of a 1:1 solution of ethyl acetate:cyclohexane with 1,3,5-
trimethoxybenzene as an internal standard (10 mM concentration) were added. The layers were 
thoroughly mixed, and the sample was centrifuged (14000 × g for 10 minutes at RT) to separate 
the phases. Afterwards, an aliquot of the organic layer was subjected to GC analysis and the 
samples are assayed by GC. 
 
Large-Scale Protein Expression. Single colonies from LB-Agar plates were picked using a 
sterile pipette tip and were used to inoculate 25 mL of LB-amp in a 125-mL unbaffled Erlenmeyer 
flask. Cultures were incubated at 37 ºC with shaking at 220 rpm overnight in an Innova 4000 
incubator. These overnight cultures (20 mL) were used to inoculate 1000 mL of HB-amp (1% v/v 
starter culture in expression culture) in a 2.8 L- Erlenmeyer flasks. The remainder of the overnight 
culture was subjected to sequence identification. The expression cultures were incubated at 37 ºC 
and 220 rpm for 2.5 hours in an Innova 42 shaker, at which point they were held on ice for 45 
minutes. Protein expression was then induced by direct addition of 1.0 mL of stock solutions 
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containing 500 mM IPTG and 1.0 mM ALA such that the final concentrations were 0.5 mM and 
1.0 mM, respectively. The cultures were shaken at 22 ºC and 140 rpm for 16 hours in an Innova 
42 shaker.  
 
Processing of Large Scale Expression Cultures for Preparative Biocatalytic Reactions. 
The corresponding 1L cultures were pelleted (5000 × g for 5 minutes at 4 ºC) and resuspended in 
40 mL of M9-N buffer. The whole cell suspensions were held on ice until the protein concentration 
could be determined (vide infra) and reactions could be run. 
 
Lysis of Whole Cell Suspensions. Whole cell suspensions from either small scale protein 
expression or large scale protein expression are lysed as follows. An aliquot of the whole cell 
suspension (3 mL) was diluted in 3 mL of M9-N buffer, and the cells were lysed by sonication on 
ice for 2 minutes at 25% amplitude (1 second on, 2 second off) using a QSonica Q500 Sonicator 
and a ½-inch tip. The sonicated cell mixture was clarified by centrifugation (14000 × g for 10 
minutes at 4 ºC), siphoning off the supernatant from the cellular debris into a fresh container. 
 
Protein Concentration Determination via CO-Binding Assay. The CO-binding assay was 
performed with clarified lysate as described above using a modified literature procedure.5 The 
extinction coefficient for ε410-490 of 0.103 M
–1 cm–1 as measured for P411BM3-CIS is used to 
estimate the concentration of the P411 enzymes disclosed in this work. UV-Vis spectra are taken 
using a Tecan SPARK instrument using untreated, 96-well flat-bottom polystyrene microplates 
(Evergreen Scientific, 290-8115-01F).  
Clarified lyase (90 μL) with the hemoprotein of interest was diluted with 90 μL of M9-N buffer 
prior to the addition of 20 μL of a 300 mM solution of sodium dithionite in M9-N. The mixture 
was thoroughly mixed, and a UV-Vis absorbance measurement was taken at the peak maximum 
at 410 nm and at 490 nm as a baseline measurement. The plate was then transferred to a vacuum 
chamber, which was evacuated and backfilled with an atmosphere of CO. The plates were allowed 
to incubate under an atmosphere of CO for 30 minutes. Once incubation was complete, a second 
UV-Vis absorbance measurement was taken at 410 nm and at 490 nm. Beer’s law was used to 
determine the hemoprotein concentration of the solution using the ΔA411-490 between the CO-bound 





Directed Evolution for Aziridine Ring Expansion 
 
Select Connections Between P450BM3 and Parent F2 
Protein Variant 
 
Mutations Relative to Wild-type P450BM3 
P450BM3 None 
 
P450BM3-CIS V78A F87V P142S T175I A184V S226R H236Q E252G T268A 
A290V L353V I366V E442K 
P411BM3-CIS V78A F87V P142S T175I A184V S226R H236Q E252G T268A 
A290V L353V I366V C400S E442K 
P411BM3-CIS P248T I263G 
L437F (Parent F.2) 
V78A F87V P142S T175I A184V S226R H236Q P248T E252G 
I263G T268A A290V L353V I366V C400S L437F E442K 
Table S1. Selected sequence differences between relevant P450/P411 variants and wild-type P450BM3. 
 
 
Evolutionary Trajectory of P411 Variants Involved in This Study 
Protein Variant 
 
Mutations Relative to Wild-type P450BM3 
(New Mutations in Bold) 
 
Parent F2 None 
Parent F2.1 G263Y 
Parent F2.2 G263Y T327V 
Parent F2.3 G263Y T327V A330T 
Parent F2.4 
 
G263Y H266P T327V A330T  
Parent F2.5 M177Q G263Y H266P T327V A330T 
Parent F2.6 M177Q G263Y H266P  
T327V A330T T436G 
Parent F2.7 M177Q L233F G263Y H266P  
T327V A330T T436G 
Parent F2.8 T149M M177Q L233F G263Y  
H266P T327V A330T T436G 
Parent F2.9 R47Q T149M M177Q L233F G263Y  
H266P T327V A330T T436G 
P411-AzetS R47Q M118K T149M M177Q L233F G263Y  
H266P T327V A330T T436G 

















Entry Changes to Conditions Above Product Observed? 
1 None Yes 
2 No Enzyme, 10 μM Hemin No 
3 No Enzyme, 10 μM Hemin, 
300 mM sodium dithionite 
No 
4 No Enzyme, 1 mg/mL BSA No 
5 No Enzyme, 1 mg/mL BSA 
300 mM sodium dithionite 
No 
6 No Enzyme, 10 μM Hemin,  
1 mg/mL BSA 
No 
7 No Enzyme, 10 μM Hemin,  
1 mg/mL BSA, 300 mM sodium dithionite 
No 
8 Buffer Only No 
9 Buffer with 300 mM sodium dithionite No 
Table S3. Control experiments performed to assess potential background reactivity. Reactions were 










Benzyl (2-bromoethyl)carbamate. To a round-bottom flask equipped 
with a stir bar: 2-bromoethylamine hydrobromide (5.00 g, 24.4 mmol, 1.0 
equiv.) was suspended in dioxane (24 mL). The suspension was chilled in 
an ice bath and 1.0 M aq. NaOH solution (30 mL) was added slowly. Once 
addition was complete, benzyl chloroformate (4.37 g, 3.66 mL, 25.6 mmol, 
1.05 equiv.) was added dropwise. The solution was allowed to ambiently warm to room 
temperature with stirring overnight. Once complete, the reaction was partitioned into 150 mL of 
diethyl ether. The aqueous layer was drained, and the organics were washed with an additional 
portion of water (30 mL) and brine (30 mL) before drying over sodium sulfate. Once dry, the 
organics were decanted from the drying agent and the volatiles were stripped under vacuum. The 
crude product was purified by silica gel column chromatography (gradient  from 100% hexanes to 
15% EtOAc in hexanes) to afford 4.65 g (74% yield) of the titled compound as a colorless oil that 
gradually solidifies upon standing. 1H NMR (400 MHz, CDCl3) δ 7.44 – 7.29 (m, 5H), 5.17 (br s, 
1H), 5.12 (s, 2H), 3.62 (q, J = 5.9 Hz, 2H), 3.48 (t, J = 5.8 Hz, 2H). The spectrum obtained is in 
accord with prior literature reports.6 
 
Benzyl (2-bromoethyl)carbamate. To a round-bottom flask equipped with a stir 
bar: benzyl (2-bromoethyl)carbamate (4.65 g, 18 mmol, 1 equiv.) was dissolved 
in DMF (90 mL). Cesium carbonate (8.80 g, 27 mmol, 1.5 equiv.) was added in a 
single portion. The reaction was allowed to stir vigorously at room temperature 
until judged complete by TLC analysis. Once complete, the reaction was 
partitioned into 180 mL of ethyl acetate and 90 mL of water. The phases were thoroughly mixed, 
and the aqueous layer was drained. The organics were washed with 5% aq. LiCl (w/w) solution 
(3x 30 mL) prior to drying over sodium sulfate. Once dry, the organics were decanted from the 
drying agent and the volatiles were stripped under vacuum. The crude product was purified by 
silica gel column chromatography (gradient from 100% hexanes to 20% EtOAc in hexanes) to 
afford 2.44 g (77% yield) of the titled compound as a colorless oil. 1H NMR (600 MHz, CDCl3) δ 
S9 






Thiophen-2-ylmethyl (2-bromoethyl)carbamate. Synthesized 
using the procedure of Marlin.8 Thiophen-2-ylmethanol (457 mg, 
0.38 mL, 4 mmol, 1.0 equiv.) and triethylamine (526 mg, 0.73 mL, 
5.2 mmol, 1.3 equiv.) were dissolved in methylene chloride (16 mL). 
The flask was chilled in an ice bath and 2-bromoethyl isocyanate 
(720 mg, 0.43 mL, 4.8 mmol, 1.2 equiv.) were added dropwise. The reaction was allowed to 
ambiently warm to RT with stirring and is allowed to stir until judged complete by TLC. Once 
complete, the volatiles were stripped under vacuum and the product purified by silica gel column 
chromatography (gradient from 100% hexanes to 25% EtOAc in hexanes) to afford 1.02 g (97% 
yield) of the titled compound as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.32 (dd, J = 5.1, 
1.2 Hz, 1H), 7.12 – 7.06 (m, 1H), 6.99 (dd, J = 5.1, 3.5 Hz, 1H), 5.26 (s, 2H), 5.19 (s, 1H), 3.60 
(q, J = 5.9 Hz, 2H), 3.46 (t, J = 5.9 Hz, 2H). 13C NMR (101 MHz, CDCl3) δ 155.82, 138.21, 
128.05, 126.83, 126.82, 61.15, 42.72, 32.35. 
 
Thiophen-2-ylmethyl aziridine-1-carboxylate. Thiophen-2-ylmethyl (2-
bromoethyl)carbamate (1.02 g, 3.86 mmol, 1 equiv.) was dissolved in DMF 
(19 mL). Cesium carbonate (1.89 g, 5.79 mmol, 1.5 equiv.) was added in a 
single portion and the reaction was vigorously stirred at RT until judged 
complete by TLC. Once finished, the reaction was partitioned into 40 mL of 
EtOAc and 20 mL of water. The layers were thoroughly mixed and the 
aqueous layer was drained. The organics were further washed with 5% aq. LiCl solution (w/w) (3x 
10 mL) prior to drying the organics over sodium sulfate. Once dry, the organics were decanted and 
the volatiles stripped under vacuum. The crude product was purified by silica gel column 
chromatography (gradient from 100% hexanes to 20% EtOAc in hexanes) to afford 707 mg (63% 
yield) of the titled compound as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.32 (dd, J = 5.1, 
1.2 Hz, 1H), 7.11 (ddt, J = 3.5, 1.3, 0.7 Hz, 1H), 6.98 (dd, J = 5.1, 3.5 Hz, 1H), 5.28 (d, J = 0.7 
Hz, 2H), 2.22 (s, 4H). 13C NMR (101 MHz, CDCl3) δ 163.35, 137.60, 128.33, 126.97, 126.81, 
62.41, 25.88. HRMS (ES+) exact mass calculated for [M+H]+ (C8H10NO2S) requires m/z 






4-Fluorobenzyl (2-bromoethyl)carbamate. Synthesized using 
the procedure of Marlin.8 4-fluorobenzyl alcohol (505 mg, 0.43 
mL, 4 mmol, 1.0 equiv.) and triethylamine (526 mg, 0.73 mL, 
5.2 mmol, 1.3 equiv.) were dissolved in methylene chloride (16 
mL). The flask was chilled in an ice bath and 2-bromoethyl 
isocyanate (720 mg, 0.43 mL, 4.8 mmol, 1.2 equiv.) was added dropwise. The reaction was 
allowed to ambiently warm to RT with stirring and was allowed to stir until judged complete by 
TLC. Once complete, the volatiles were stripped under vacuum and the product purified by silica 
gel column chromatography (gradient from 100% hexanes to 25% EtOAc in hexanes) to afford 
830 mg (75% yield) of the titled compound as a white solid. 1H NMR (400 MHz, CDCl3) δ 7.38 – 
7.30 (m, 2H), 7.09 – 6.99 (m, 2H), 5.18 (br s, 1H), 5.07 (s, 2H), 3.61 (q, J = 5.9 Hz, 2H), 3.47 (t, 
J = 5.8 Hz, 2H).13C NMR (101 MHz, CDCl3) δ 162.62 (d, J = 246.8 Hz), 156.00, 132.06 (d, J = 
3.3 Hz), 130.13 (d, J = 8.2 Hz), 115.46 (d, J = 21.5 Hz), 66.24, 42.72, 32.45. 19F NMR (282 MHz, 
CDCl3) δ -113.76 (m). HRMS (ES+) exact mass calculated for [M+H+CH3CN]
+ (C12H15BrFN2O2) 
requires m/z 317.0301, found m/z 317.0328. 
 
4-Fluorobenzyl aziridine-1-carboxylate. 4-fluorobenzyl (2-
bromoethyl)carbamate (830 mg, 3.00 mmol, 1 equiv.) was dissolved in 
DMF (15 mL). Cesium carbonate (1.47 g, 4.50 mmol, 1.5 equiv.) was 
added in a single portion and the reaction was vigorously stirred at RT 
until judged complete by TLC. Once finished, the reaction was 
partitioned into 30 mL of EtOAc and 15 mL of water. The layers were 
thoroughly mixed, and the aqueous layer was drained. The organics were further washed with 5% 
aq. LiCl solution (w/w) (3x 10 mL) prior to drying the organics over sodium sulfate. Once dry, the 
organics were decanted and the volatiles stripped under vacuum. The crude product was purified 
by silica gel column chromatography (gradient from 100% hexanes to 20% EtOAc in hexanes) to 
afford 414 mg (71% yield) of the titled compound as a colorless oil. 1H NMR (400 MHz, CDCl3) 
δ 7.40 – 7.32 (m, 2H), 7.13 – 6.94 (m, 2H), 5.09 (s, 2H), 2.22 (s, 4H). 13C NMR (101 MHz, CDCl3) 
δ 163.50, 162.71 (d, J = 247.1 Hz), 131.54 (d, J = 3.3 Hz), 130.25 (d, J = 8.3 Hz), 115.49 (d, J = 
21.6 Hz), 67.50, 25.86. 19F NMR (282 MHz, CDCl3) δ -112.79 (tt, J = 9.0, 5.7 Hz). HRMS (ES+) 






3-Fluorobenzyl (2-bromoethyl)carbamate. Synthesized using 
the procedure of Marlin.8 3-Fluorobenzyl alcohol (505 mg, 0.43 
mL, 4 mmol, 1.0 equiv.) and triethylamine (526 mg, 0.73 mL, 
5.2 mmol, 1.3 equiv.) were dissolved in methylene chloride (16 
mL). The flask was chilled in an ice bath and 2-bromoethyl 
isocyanate (720 mg, 0.43 mL, 4.8 mmol, 1.2 equiv.) was added 
dropwise. The reaction was allowed to ambiently warm to RT with stirring and was allowed to stir 
until judged complete by TLC. Once complete, the volatiles were stripped under vacuum and the 
product purified by silica gel column chromatography (gradient from 100% hexanes to 25% 
EtOAc in hexanes) to afford 980 mg (89% yield) of the titled compound as a colorless oil. 1H 
NMR (400 MHz, CDCl3) δ 7.32 (td, J = 8.0, 5.8 Hz, 1H), 7.15 – 7.08 (m, 2H), 7.06 (dt, J = 9.5, 
2.1 Hz, 1H), 7.04 – 6.97 (m, 1H), 5.24 (s, 1H), 5.10 (s, 2H), 3.61 (q, J = 5.9 Hz, 2H), 3.47 (t, J = 
5.8 Hz, 2H). 13C NMR (101 MHz, CDCl3) δ 162.81 (d, J = 246.3 Hz), 155.89, 138.76 (d, J = 7.3 
Hz), 130.09 (d, J = 8.1 Hz), 123.34 (d, J = 3.0 Hz), 115.04 (d, J = 21.1 Hz), 114.74 (d, J = 21.9 
Hz), 66.03, 42.74, 32.38. 19F NMR (282 MHz, CDCl3) δ -113.02 (td, J = 9.0, 5.7 Hz). HRMS 
(ES+) exact mass calculated for [M+H]+ (C10H12BrFNO2) requires m/z 276.0035, found m/z 
276.0047. 
 
3-Fluorobenzyl aziridine-1-carboxylate. 3-Fluorobenzyl (2-
bromoethyl)carbamate (980 mg, 3.55 mmol, 1 equiv.) was dissolved in 
DMF (18 mL). Cesium carbonate (1.73 g, 5.33 mmol, 1.5 equiv.) was 
added in a single portion and the reaction was vigorously stirred at RT 
until judged complete by TLC. Once finished, the reaction was 
partitioned into 30 mL of EtOAc and 15 mL of water. The layers were 
thoroughly mixed, and the aqueous layer was drained. The organics were further washed with 5% 
aq. LiCl solution (w/w) (3x 10 mL) prior to drying the organics over sodium sulfate. Once dry, the 
organics were decanted and the volatiles stripped under vacuum. The crude product was purified 
by silica gel column chromatography (gradient from 100% hexanes to 20% EtOAc in hexanes) to 
afford 525 mg (76% yield) of the titled compound as a colorless oil. 1H NMR (400 MHz, CDCl3) 
δ 7.32 (td, J = 7.9, 5.8 Hz, 1H), 7.13 (ddt, J = 7.6, 1.6, 0.8 Hz, 1H), 7.08 (dt, J = 9.6, 2.1 Hz, 1H), 
7.05 – 6.98 (m, 1H), 5.12 (s, 2H), 2.24 (s, 4H). 13C NMR (101 MHz, CDCl3) δ 163.38, 162.80 (d, 
J = 246.5 Hz), 138.17 (d, J = 7.4 Hz), 130.13 (d, J = 8.1 Hz), 123.46 (d, J = 3.0 Hz), 115.20 (d, J 
= 21.0 Hz), 114.85 (d, J = 22.0 Hz), 67.26 (d, J = 1.9 Hz), 25.88. 19F NMR (282 MHz, CDCl3) δ -
S12 
112.94 (td, J = 9.0, 5.8 Hz). HRMS (ES+) exact mass calculated for [M+H]+ (C10H11FNO2) 
requires m/z 196.0774, found m/z 196.0748. 
 
 
2-Fluorobenzyl (2-bromoethyl)carbamate. Synthesized using 
the procedure of Marlin.8 2-Fluorobenzyl alcohol (505 mg, 0.43 
mL, 4 mmol, 1.0 equiv.) and triethylamine (526 mg, 0.73 mL, 5.2 
mmol, 1.3 equiv.) was dissolved in methylene chloride (16 mL). 
The flask was chilled in an ice bath and 2-bromoethyl isocyanate 
(720 mg, 0.43 mL, 4.8 mmol, 1.2 equiv.) was added dropwise. The 
reaction was allowed to ambiently warm to RT with stirring and was allowed to stir until judged 
complete by TLC. Once complete, the volatiles were stripped under vacuum and the product 
purified by silica gel column chromatography (gradient from 100% hexanes to 25% EtOAc in 
hexanes) to afford 970 mg (88% yield) of the titled compound as a colorless oil. 1H NMR (400 
MHz, CDCl3) δ 7.40 (td, J = 7.5, 1.8 Hz, 1H), 7.32 (tdd, J = 7.4, 5.3, 1.8 Hz, 1H), 7.14 (td, J = 7.5, 
1.2 Hz, 1H), 7.07 (ddd, J = 9.7, 8.2, 1.2 Hz, 1H), 5.19 (s, 2H), 5.19 (br s, 1H -- overlaps with 
benzylic protons), 3.61 (q, J = 5.9 Hz, 2H), 3.47 (t, J = 5.9 Hz, 2H). 13C NMR (101 MHz, CDCl3) 
δ 160.97 (d, J = 248.5 Hz), 155.95, 130.59 (d, J = 3.9 Hz), 130.21 (d, J = 8.2 Hz), 124.14 (d, J = 
3.7 Hz), 123.38 (d, J = 14.4 Hz), 115.46 (d, J = 21.2 Hz), 60.86 (d, J = 4.3 Hz), 42.75, 32.42. 19F 
NMR (282 MHz, CDCl3) δ -118.37 (m). HRMS (ES+) exact mass calculated for [M+H]
+ 
(C10H12BrFNO2) requires m/z 276.0035, found m/z 276.0042. 
2-Fluorobenzyl aziridine-1-carboxylate. 2-Fluorobenzyl (2-
bromoethyl)carbamate (970 mg, 3.51 mmol, 1 equiv.) was dissolved in 
DMF (18 mL). Cesium carbonate (1.72 g, 5.27 mmol, 1.5 equiv.) was 
added in a single portion and the reaction was vigorously stirred at RT 
until judged complete by TLC. Once finished, the reaction was 
partitioned into 30 mL of EtOAc and 15 mL of water. The layers were 
thoroughly mixed, and the aqueous layer was drained. The organics were further washed with 5% 
aq. LiCl solution (w/w) (3x 10 mL) prior to drying the organics over sodium sulfate. Once dry, the 
organics were decanted and the volatiles stripped under vacuum. The crude product was purified 
by silica gel column chromatography (gradient from 100% hexanes to 20% EtOAc in hexanes) to 
afford 495 mg (72% yield) of the titled compound as a colorless oil. 1H NMR (400 MHz, CDCl3) 
δ 7.40 (td, J = 7.5, 1.9 Hz, 1H), 7.33 (tdd, J = 7.5, 5.3, 1.8 Hz, 1H), 7.14 (td, J = 7.5, 1.2 Hz, 1H), 
7.07 (ddd, J = 9.6, 8.2, 1.1 Hz, 1H), 5.20 (s, 2H), 2.24 (s, 4H).13C NMR (101 MHz, CDCl3) δ 
163.47, 160.98 (d, J = 248.5 Hz), 130.57 (d, J = 3.7 Hz), 130.34 (d, J = 8.2 Hz), 124.15 (d, J = 3.7 
Hz), 122.87 (d, J = 14.6 Hz), 115.48 (d, J = 21.2 Hz), 62.21 (d, J = 4.2 Hz), 25.90. 19F NMR (282 




Propyl glycinate hydrochloride. To a 100-mL round-bottom flask 
equipped with a stir bar, septum, and drying tube: glycine (1.50 g, 20 
mmol, 1.0 equiv.) was suspended in n-propanol (30 mL). The 
suspension was chilled in an ice bath with stirring prior to the dropwise 
addition of thionyl chloride (10.7 g, 6.56 mL, 90 mmol, 4.5 equiv.). 
Once addition was complete and the initial exotherm had subsided, the septum with drying tube 
was replaced with a reflux condenser with a drying tube and the solution was heated to 70 °C with 
stirring for 20 hours. When done, the reaction was allowed to cool to RT and the volatiles were 
stripped under vacuum. The product was precipitated by blanketing the crude oil with about 10 
mL of diethyl ether and gently scratching to induce precipitation. The resultant solid was isolated 
by vacuum filtration, washing liberally with additional diethyl ether, and was thoroughly dried 
under vacuum to afford 2.42 g (79% isolated yield) of the titled compound as a white solid. 1H 
NMR (400 MHz, DMSO) δ 8.75 – 8.38 (br s, 3H), 4.10 (t, J = 6.6 Hz, 2H), 3.77 (s, 2H), 1.62 (h, 
J = 7.4 Hz, 2H), 0.90 (t, J = 7.4 Hz, 3H). 13C NMR (101 MHz, DMSO-d6) δ 167.65, 66.82, 39.10 
(obscured by DMSO-d6; assigned via HSQC), 21.42, 10.17. HRMS (ES+) exact mass calculated 
for [M+H+CH3CN]
+ (C12H15BrFN2O2) requires m/z 317.0301, found m/z 317.0328. HRMS (ES+) 
exact mass calculated for [M+H]+ (C5H12NO2) requires m/z 118.0868, found m/z 118.0898. 
 
Propyl 2-diazoacetae (propyl diazoacetate). This procedure was 
adapted from that of Searle for the synthesis of ethyl diazoacetate.9 Safety 
note: the procedure reported by Searle was performed on a 1-mole scale: 
our procedure is a hundred-fold reduction in scale as a matter of safety. 
Work should be performed in a well-ventilated fume hood.  
To a 40-mL vial: propyl glycinate hydrochloride (1.54 g, 10 mmol, 1 equiv.) was added to a 
suspension of methylene chloride (2.5 mL) in water (6 mL). The solution was chilled in an ice bath 
prior to the addition of sodium nitrite (828 mg, 12 mmol, 1.2 equiv.) in a single portion. Once 
dissolved, a single drop of concentrated sulfuric acid was added, resulting in bubbling of the 
solution and the development of a yellow color. The solution was allowed to stir for 30 minutes 
on ice. Once complete, the reaction was transferred to a separatory funnel and diluted with 20 mL 
of methylene chloride. The aqueous layer was separated, and the organics were washed with 
saturated sodium bicarbonate (2x 5 mL) and brine (1x 5 mL) prior to drying over sodium sulfate. 
Once dry, the organics were decanted and the volatiles were stripped under vacuum, going no 
lower than 130 torr and spinning the flask in an ice-water bath. The resulting residue was purified 
by silica gel column chromatography (gradient from pentanes to 10% diethyl ether in pentanes, 
concentrating fractions as before) to afford 1.27 g (99% yield) of the titled compound as a yellow 
S14 
oil. 1H NMR (400 MHz, CDCl3) δ 4.73 (s, 1H), 4.12 (t, J = 6.7 Hz, 2H), 1.67 (h, J = 7.4 Hz, 1H), 






Isopropyl glycinate hydrochloride. To a 100-mL round-bottom flask 
equipped with a stir bar, septum, and drying tube: glycine (1.50 g, 20 mmol, 
1.0 equiv.) was suspended in isopropanol (30 mL). The suspension was 
chilled in an ice bath with stirring prior to the dropwise addition of thionyl 
chloride (10.7 g, 6.56 mL, 90 mmol, 4.5 equiv.). Once addition was 
complete and the initial exotherm had subsided, the septum with drying tube was replaced with a 
reflux condenser with a drying tube and the solution was heated to 70 °C with stirring for 20 hours. 
When done, the reaction was allowed to cool to RT and the volatiles were stripped under vacuum. 
The product was precipitated by blanketing the crude oil with about 10 mL of diethyl ether and 
gently scratching to induce precipitation. The resultant solid was isolated by vacuum filtration, 
washing liberally with additional diethyl ether, and was thoroughly dried under vacuum to afford 
2.33 g (76% isolated yield) of the titled compound as a white solid. 1H NMR (400 MHz, DMSO) 
δ 8.53 (br s, 3H), 4.99 (hept, J = 6.3 Hz, 1H), 3.71 (q, J = 6.2 Hz, 2H), 1.23 (d, J = 6.3 Hz, 6H). 
The chemical shifts are in accord with prior literature reports.11 
 
Isopropyl 2-diazoacetae (isopropyl diazoacetate). This procedure was 
adapted from that of Searle for the synthesis of ethyl diazoacetate.9 Safety 
note: the procedure reported by Searle was performed on a 1-mole scale: our 
procedure is a hundred-fold reduction in scale as a matter of safety. Work 
should be performed in a well-ventilated fume hood.  
To a 40-mL vial: isopropyl glycinate hydrochloride (1.54 g, 10 mmol, 1 equiv.) was added to a 
suspension of methylene chloride (2.5 mL) in water (6 mL). The solution was chilled in an ice bath 
prior to the addition of sodium nitrite (828 mg, 12 mmol, 1.2 equiv.) in a single portion. Once 
dissolved, a single drop of concentrated sulfuric acid was added, resulting in bubbling of the 
solution and the development of a yellow color. The solution was allowed to stir for 30 minutes 
on ice. Once complete, the reaction was transferred to a separatory funnel and diluted with 20 mL 
of methylene chloride. The aqueous layer was separated, and the organics were washed with 
saturated sodium bicarbonate (2x 5 mL) and brine (1x 5 mL) prior to drying over sodium sulfate. 
S15 
Once dry, the organics were decanted and the volatiles were stripped under vacuum, going no 
lower than 130 torr and spinning the flask in an ice-water bath. The resulting residue was purified 
by silica gel column chromatography (gradient from pentanes to 10% diethyl ether in pentanes) to 
afford 738 mg (58% yield) of the titled compound as a yellow oil. 1H NMR (400 MHz, CDCl3) δ 
5.09 (hept, J = 6.3 Hz, 1H), 4.69 (s, 1H), 1.26 (d, J = 6.3 Hz, 6H). The chemical shifts are in accord 




Methyl 2-diazoacetae (Methyl diazoacetate). 
This procedure was adapted from that of Searle for the synthesis of ethyl 
diazoacetate.9 Safety note: the procedure reported by Searle was performed on 
a 1-mole scale: our procedure is a hundred-fold reduction in scale as a matter 
of safety. Work should be performed in a well-ventilated fumehood. 
To a 40-mL vial: glycine methyl ester hydrochloride (1.26 g, 10 mmol, 1 equiv.) was added to a 
suspension of methylene chloride (2.5 mL) in water (6 mL). The solution was chilled on an ice 
bath prior to the addition of sodium nitrite (828 mg, 12 mmol, 1.2 equiv.) in a single portion. Once 
dissolved, a single drop of concentrated sulfuric acid was added, resulting in bubbling of the 
solution and the development of a yellow color. The solution was allowed to stir for 30 minutes 
on ice. Once complete, the reaction was transferred to a separatory funnel and diluted with 20 mL 
of methylene chloride. The aqueous layer was separated, and the organics were washed with 
saturated sodium bicarbonate (2x 5 mL) and brine (1x 5 mL) prior to drying over sodium sulfate. 
Once dry, the organics were decanted and the volatiles were stripped under vacuum, going no 
lower than 200 torr and spinning the flask in an ice-water bath. The resulting residue was purified 
by silica gel column chromatography (gradient from pentanes to 10% diethyl ether in pentanes) to 
afford 584 mg (58% yield) of the titled compound as a yellow oil. 1H NMR (400 MHz, CDCl3) δ 









(±)-Ethyl azetidine-2-carboxylate hydrochloride. To an oven-dried 8-mL dram 
vial equipped with a stir bar, septum, and drying tube: (±)-azetidine-2-carboxylic 
acid (100 mg, 1 mmol, 1 equiv.) was suspended in ethanol (1.25 mL). The reaction 
was chilled in an ice bath, and thionyl chloride (0.15 mL, 2 mmol, 2 equiv.) was 
added dropwise. The reaction was allowed to ambiently warm to RT with stirring 
until judged complete by TLC. Once done, the solution was concentrated directly from this dram 
vial under vacuum to remove volatiles, and the crude product was carried forward with no further 
purification. For the purposes of the subsequent reaction, the yield was presumed to be 
quantitative. 
 
(±)-1-Benzyl 2-ethyl azetidine-1,2-dicarboxylate. The crude (±)-ethyl 
azetidine-2-carboxylate hydrochloride (165.62 mg, 1 mmol, 1 equiv.) 
synthesized above is suspended in methylene chloride (5 mL) and the 
dram vial is equipped with a stir bar, a septum, and a drying tube. The 
vial is chilled in an ice bath prior to the addition of triethylamine (0.69 
mL, 5 mmol, 5 equiv.). Once addition is complete, benzyl chloroformate 
(0.29 mL, 2 mmol, 2 equiv.) is added dropwise. The reaction is allowed to warm to RT and stirring 
is continued until the reaction is judged complete by TLC analysis. Once complete, the reaction is 
transferred to a separatory funnel and quenched with 5 mL of saturated sodium bicarbonate 
solution. The layers are thoroughly mixed, and the aqueous layer is removed. The organic layer is 
washed with water (1x 5 mL) and brine (1x 5 mL) prior to drying over sodium sulfate. Once dry, 
the organics are decanted and the volatiles are removed under vacuum. The crude product is 
purified by silica gel column chromatography (gradient from hexanes to 33% EtOAc in hexanes) 
to afford 165 mg (63% yield) of the titled compound a colorless oil. 1H NMR (400 MHz, CDCl3) 
δ 7.39 – 7.27 (m, 5H), 5.10 (m, 2H), 4.68 (dd, J = 9.3, 5.3 Hz, 1H), 4.19 (br s, 2H), 4.12 (m, 1H), 
3.97 (m, 1H), 2.57 (dtd, J = 11.5, 9.2, 6.3 Hz, 1H), 2.22 (ddt, J = 11.3, 9.0, 5.5 Hz, 1H), 1.30 – 
1.17 (br m, 3H).  
 
S17 
1-Benzyl 2-ethyl (S)-azetidine-1,2-dicarboxylate. This compound was 
synthesized using the analogous procedure to the racemate, except (S)-
azetidine-2-carboxylic acid was used instead of racemic azetidine-2-
carboxylic acid. This procedure yielded 82 mg (32% isolated yield) of 
the titled compound as a colorless oil over two steps. 1H NMR (400 
MHz, CDCl3) δ 7.39 – 7.27 (m, 5H), 5.10 (m, 2H), 4.68 (dd, J = 9.3, 5.3 
Hz, 1H), 4.19 (br s, 2H), 4.12 (m, 1H), 3.97 (m, 1H), 2.57 (dtd, J = 11.5, 9.2, 6.3 Hz, 1H), 2.22 




Thiophen-2-ylmethyl 1H-imidazole-1-carboxylate. Synthesized 
using the procedure reported by Snaddon.13 To an oven-dried 8-mL 
dram vial equipped with a stir bar, septum, and drying tube: 2-
thiophenemethanol (343 mg, 0.28 mL, 3 mmol, 1 equiv.) was dissolved 
in benzene (3 mL) and the solution was chilled in an ice bath. 
Carbonyldiimidazole (CDI) (503 mg, 3.3 mmol, 1.1 equiv.) was added by quickly removing the 
septum and pouring in the solid reagent in a single portion. Once the initial exotherm subsided, the 
reaction was allowed to stir at RT until judged complete by TLC. Once finished, a small amount 
of methylene chloride was added to fully dissolve all solids. The reaction mixture was washed 
with water (2x 1.5 mL) and brine (1.5 mL) prior to drying over sodium sulfate. Once dry, the 
organics were decanted, and the volatiles were removed under vacuum to afford 500 mg (80% 
yield) of the titled compound as a colorless oil. The purity of the crude was sufficient to carry 
forward without further purification. 1H NMR (600 MHz, CDCl3) δ 8.15 (2, 1H), 7.43 (t, J = 1.4 
Hz, 1H), 7.41 (dd, J = 5.1, 1.3 Hz, 1H), 7.23 (dd, J = 3.3, 1.3 Hz, 1H), 7.06 (m, 1H), 7.04 (m, 1H), 
5.58 (s, 2H). The spectral data is consistent with prior literature reports.14 
 
S18 
(±)-Ethyl azetidine-2-carboxylate hydrochloride. To an oven-dried 8-mL dram 
vial equipped with a stir bar, septum, and drying tube: (±)-azetidine-2-carboxylic 
acid (100 mg, 1 mmol, 1 equiv.) was suspended in ethanol (1.25 mL). The reaction 
was chilled in an ice bath, and thionyl chloride (0.15 mL, 2 mmol, 2 equiv.) was 
added dropwise. The reaction was allowed to ambiently warm to RT with stirring 
until judged complete by TLC. Once done, the solution was concentrated directly from this dram 
vial under vacuum to remove volatiles, and the crude product was carried forward with no further 
purification. For the purposes of the subsequent reaction, the yield was presumed to be 
quantitative. 
 
(±)-2-Ethyl-1-(thiophen-2-ylmethyl) azetidine-1,2-dicarboxylate. The 
crude (±)-ethyl azetidine-2-carboxylate hydrochloride (165.62 mg, 1 
mmol, 1 equiv.) synthesized above was suspended in methylene chloride 
(3 mL) and the dram vial was equipped with a stir bar, a septum, and a 
drying tube. The vial was chilled in an ice bath prior to the addition of 
triethylamine (0.69 mL, 5 mmol, 5 equiv.). Once addition was complete, 
thiophen-2-ylmethyl 1H-imidazole-1-carboxylate (416 mg, 2 mmol, 2 equiv.) was added to the 
mixture in 2 mL of methylene chloride. The reaction was allowed to warm to RT and stirring was 
continued until the reaction is judged complete by TLC analysis. When done, the reaction was 
transferred to a separatory funnel and diluted with 5 mL of methylene chloride. The reaction is 
washed with 1.0 M HCl (5 mL), sat. aq. NaHCO3 (5 mL), and brine (5 mL) prior to drying over 
sodium sulfate. Once dry, the organics were decanted and the volatiles stripped under vacuum. 
The crude residue was purified by silica gel column chromatography (gradient from 100% hexanes 
to 30% EtOAc in hexanes) to afford 93 mg (35% yield) of the titled compound as a colorless oil. 
1H NMR (600 MHz, CDCl3) δ 7.29 (d, J = 5.1 Hz, 1H), 7.09 – 7.04 (m, 1H), 6.96 (t, J = 4.3 Hz, 
1H), 5.21 (m, 2H), 4.66 (dd, J = 9.4, 5.3 Hz, 1H), 4.20 (br s, 2H), 4.16 – 4.06 (m, 1H), 3.96 (m, 





4-Fluorobenzyl 1H-imidazole-1-carboxylate. Synthesized using 
the procedure reported by Snaddon.13 To an oven-dried 8 mL dram 
vial equipped with a stir bar, septum, and drying tube: 4-
fluorobenzyl alcohol (378 mg, 0.33 mL, 3 mmol, 1 equiv.) is 
dissolved in benzene (3 mL) and the solution is chilled in an ice bath. 
Carbonyldiimidazole (CDI) (503 mg, 3.3 mmol, 1.1 equiv.) is added by quickly removing the 
septum and pouring in the solid reagent in a single portion. Once the initial exotherm subsided, the 
reaction is allowed to stir at RT until judged complete by TLC. Once finished, a small amount of 
methylene chloride is added to fully dissolve all solids. The reaction mixture is washed with water 
(2x 1.5 mL) and brine (1.5 mL) prior to drying over sodium sulfate. Once dry, the organics are 
decanted and the volatiles are removed under vacuum to afford 560 mg (85% yield) of the titled 
compound as a colorless oil. The purity of the crude is sufficient to carry forward without further 
purification. 1H NMR (600 MHz, CDCl3) δ 8.13 (s, 1H), 7.47 – 7.41 (m, 3H), 7.14 – 7.01 (m, 3H), 
5.38 (s, 2H). The spectral data is consistent with prior literature reports.15 
 
(±)-Ethyl azetidine-2-carboxylate hydrochloride. To an oven-dried 8-mL dram 
vial equipped with a stir bar, septum, and drying tube: (±)-azetidine-2-carboxylic 
acid (100 mg, 1 mmol, 1 equiv.) was suspended in ethanol (1.25 mL). The reaction 
was chilled in an ice bath, and thionyl chloride (0.15 mL, 2 mmol, 2 equiv.) was 
added dropwise. The reaction was allowed to ambiently warm to RT with stirring 
until judged complete by TLC. Once done, the solution was concentrated directly from this dram 
vial under vacuum to remove volatiles, and the crude product was carried forward with no further 
purification. For the purposes of the subsequent reaction, the yield was presumed to be 
quantitative. 
 
(±)-2-ethyl-1-(4-fluorobenzyl) azetidine-1,2-dicarboxylate. The 
crude (±)-ethyl azetidine-2-carboxylate hydrochloride (165.62 mg, 1 
mmol, 1 equiv.) synthesized above was suspended in methylene 
chloride (3 mL) and the dram vial was equipped with a stir bar, a 
septum, and a drying tube. The vial was chilled in an ice bath prior to 
the addition of triethylamine (0.69 mL, 5 mmol, 5 equiv.). Once 
addition was complete, 4-fluorobenzyl 1H-imidazole-1-carboxylate (440 mg, 2 mmol, 2 equiv.) 
was added to the mixture in 2 mL of methylene chloride. The reaction was allowed to warm to RT 
and stirring is continued until the reaction was judged complete by TLC analysis. When done, the 
reaction was transferred to a separatory funnel and diluted with 5 mL of methylene chloride. The 
reaction was washed with 1.0 M HCl (5 mL), sat. aq. NaHCO3 (5 mL), and brine (5 mL) prior to 
drying over sodium sulfate. Once dry, the organics were decanted and the volatiles stripped under 
vacuum. The crude residue was purified by silica gel column chromatography (gradient from 
100% hexanes to 30% EtOAc in hexanes) to afford 71 mg (25% yield) of the titled compound as 
S20 
a colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.31 (m, 2H), 7.08 – 6.97 (m, 2H), 5.14 – 4.96 (m, 
2H), 4.74 – 4.61 (m, 1H), 4.18 (br s, 2H), 4.10 (m, 1H), 4.02 – 3.86 (m, 1H), 2.56 (dddd, J = 11.5, 




3-Fluorobenzyl 1H-imidazole-1-carboxylate. Synthesized using 
the procedure reported by Snaddon.13 To an oven-dried 8-mL dram 
vial equipped with a stir bar, septum, and drying tube: 3-
fluorobenzyl alcohol (378 mg, 0.33 mL, 3 mmol, 1 equiv.) was 
dissolved in benzene (3 mL) and the solution was chilled in an ice 
bath. Carbonyldiimidazole (CDI) (503 mg, 3.3 mmol, 1.1 equiv.) was added by quickly removing 
the septum and pouring in the solid reagent in a single portion. Once the initial exotherm subsided, 
the reaction was allowed to stir at RT until judged complete by TLC. Once finished, a small amount 
of methylene chloride was added to fully dissolve all solids and the mixture was diluted in 5 mL 
of EtOAc. The reaction mixture was washed with water (2x 1.5 mL) and brine (1.5 mL) prior to 
drying over sodium sulfate. Once dry, the organics were decanted, and the volatiles removed under 
vacuum to afford 660 mg (quantiative yield) of the titled compound as a colorless oil. The purity 
of the crude was sufficient to carry forward without further purification. 1H NMR (400 MHz, 
CDCl3) δ 8.15 (t, J = 1.1 Hz, 1H), 7.44 (t, J = 1.5 Hz, 1H), 7.39 (td, J = 8.0, 5.8 Hz, 1H), 7.32 (m, 
1H), 7.22 (m, 1H), 7.18 – 7.05 (m, 3H), 5.40 (s, 2H). The spectral data is consistent with prior 
literature reports.16 
 
(±)-Ethyl azetidine-2-carboxylate hydrochloride. To an oven-dried 8-mL dram 
vial equipped with a stir bar, septum, and drying tube: (±)-azetidine-2-carboxylic 
acid (100 mg, 1 mmol, 1 equiv.) was suspended in ethanol (1.25 mL). The reaction 
was chilled in an ice bath, and thionyl chloride (0.15 mL, 2 mmol, 2 equiv.) was 
added dropwise. The reaction was allowed to ambiently warm to RT with stirring 
until judged complete by TLC. Once done, the solution was concentrated directly from this dram 
S21 
vial under vacuum to remove volatiles, and the crude product was carried forward with no further 
purification. For the purposes of the subsequent reaction, the yield was presumed to be 
quantitative. 
 
(±)-2-Ethyl-1-(3-fluorobenzyl) azetidine-1,2-dicarboxylate. The 
crude (±)-ethyl azetidine-2-carboxylate hydrochloride (165.62 mg, 1 
mmol, 1 equiv.) synthesized above was suspended in methylene 
chloride (3 mL) and the dram vial was equipped with a stir bar, a 
septum, and a drying tube. The vial was chilled in an ice bath prior 
to the addition of triethylamine (0.69 mL, 5 mmol, 5 equiv.). Once 
addition was complete, 3-fluorobenzyl 1H-imidazole-1-carboxylate (440 mg, 2 mmol, 2 equiv.) 
was added to the mixture in 2 mL of methylene chloride. The reaction was allowed to warm to RT 
and stirring was continued until the reaction was judged complete by TLC analysis. When done, 
the reaction was transferred to a separatory funnel and diluted with 5 mL of methylene chloride. 
The reaction was washed with 1.0 M HCl (5 mL), sat. aq. NaHCO3 (5 mL), and brine (5 mL) prior 
to drying over sodium sulfate. Once dry, the organics were decanted and the volatiles stripped 
under vacuum. The crude residue was purified by silica gel column chromatography (gradient from 
100% hexanes to 30% EtOAc in hexanes) to afford 104 mg (37% yield) of the titled compound as 
a colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.30 (td, J = 7.9, 5.8 Hz, 1H), 7.13 – 6.94 (m, 3H), 
5.22 – 4.98 (m, 2H), 4.70 (dd, J = 9.3, 5.3 Hz, 1H), 4.27 – 4.17 (m, 2H), 4.16 – 4.08 (m, 1H), 3.99 
(ddd, J = 9.1, 8.1, 5.6 Hz, 1H), 2.59 (dtd, J = 11.6, 9.2, 6.3 Hz, 1H), 2.23 (ddt, J = 11.4, 9.1, 5.5 





2-Fluorobenzyl 1H-imidazole-1-carboxylate. Synthesized using the 
procedure reported by Snaddon.13 To an oven-dried 8-mL dram vial 
equipped with a stir bar, septum, and drying tube: 2-fluorobenzyl 
alcohol (378 mg, 0.32 mL, 3 mmol, 1 equiv.) was dissolved in benzene 
(3 mL) and the solution was chilled in an ice bath. Carbonyldiimidazole 
(CDI) (503 mg, 3.3 mmol, 1.1 equiv.) was added by quickly removing the septum and pouring in 
the solid reagent in a single portion. Once the initial exotherm subsided, the reaction was allowed 
to stir at RT until judged complete by TLC. Once finished, a small amount of methylene chloride 
was added to fully dissolve all solids and the mixture is diluted in 5 mL of EtOAc. The reaction 
mixture was washed with water (2x 1.5 mL) and brine (1.5 mL) prior to drying over sodium sulfate. 
Once dry, the organics were decanted and the volatiles were removed under vacuum to afford 580 
mg (88% yield) of the titled compound as a colorless oil. The purity of the crude was sufficient to 
carry forward without further purification. 1H NMR (400 MHz, CDCl3) δ 8.15 (t, J = 1.1 Hz, 1H), 
7.50 – 7.37 (m, 3H), 7.23 – 7.09 (m, 2H), 7.06 (dd, J = 1.7, 0.8 Hz, 1H), 5.49 (s, 2H). 13C NMR 
(101 MHz, CDCl3) δ 161.25 (d, J = 249.9 Hz), 148.49, 137.13, 131.39 (d, J = 8.3 Hz), 131.15 (d, 
J = 3.3 Hz), 130.63, 124.42 (d, J = 3.7 Hz), 121.22 (d, J = 14.5 Hz), 117.15, 115.83 (d, J = 20.9 
Hz), 63.80 (d, J = 4.2 Hz). 19F NMR (282 MHz, CDCl3) δ -117.51 (m). HRMS (ES+) exact mass 
calculated for [M+H]+ (C11H10FN2O2) requires m/z 211.0726, found m/z 211.0726. 
  
(±)-Ethyl azetidine-2-carboxylate hydrochloride. To an oven-dried 8-mL dram 
vial equipped with a stir bar, septum, and drying tube: (±)-azetidine-2-carboxylic 
acid (100 mg, 1 mmol, 1 equiv.) was suspended in ethanol (1.25 mL). The reaction 
was chilled in an ice bath, and thionyl chloride (0.15 mL, 2 mmol, 2 equiv.) was 
added dropwise. The reaction was allowed to ambiently warm to RT with stirring 
until judged complete by TLC. Once done, the solution was concentrated directly from this dram 
vial under vacuum to remove volatiles, and the crude product was carried forward with no further 
purification. For the purposes of the subsequent reaction, the yield was presumed to be 
quantitative. 
 
(±)-2-Ethyl-1-(2-fluorobenzyl) azetidine-1,2-dicarboxylate. The 
crude (±)-ethyl azetidine-2-carboxylate hydrochloride (165.62 mg, 1 
mmol, 1 equiv.) synthesized above was suspended in methylene 
chloride (3 mL) and the dram vial was equipped with a stir bar, a 
septum, and a drying tube. The vial was chilled in an ice bath prior to 
the addition of triethylamine (0.69 mL, 5 mmol, 5 equiv.). Once 
addition was complete, 2-fluorobenzyl 1H-imidazole-1-carboxylate (440 mg, 2 mmol, 2 equiv.) 
was added to the mixture in 2 mL of methylene chloride. The reaction was allowed to warm to RT 
and stirring was continued until the reaction was judged complete by TLC analysis. When done, 
the reaction was transferred to a separatory funnel and diluted with 5 mL of methylene chloride. 
The reaction was washed with 1.0 M HCl (5 mL), sat. aq. NaHCO3 (5 mL), and brine (5 mL) prior 
to drying over sodium sulfate. Once dry, the organics were decanted and the volatiles stripped 
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under vacuum. The crude residue was purified by silica gel column chromatography (gradient from 
100% hexanes to 30% EtOAc in hexanes) to afford 102 mg (36% yield) of the titled compound as 
a colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.38 (m, 1H), 7.29 (m, 1H), 7.12 (m, 1H), 7.04 (m, 
1H), 5.17 (q, J = 12.7 Hz, 2H), 4.68 (dd, J = 9.3, 5.3 Hz, 1H), 4.19 (m, 2H), 4.11 (td, J = 8.6, 6.3 
Hz, 1H), 3.97 (td, J = 8.6, 8.2, 5.7 Hz, 1H), 2.57 (dtd, J = 11.6, 9.2, 6.3 Hz, 1H), 2.21 (ddt, J = 




 (±)-Propyl azetidine-2-carboxylate hydrochloride. To an oven-dried 8-mL 
dram vial equipped with a stir bar, septum, and drying tube: (±)-azetidine-2-
carboxylic acid (50 mg, 1 mmol, 1 equiv.) was suspended in n-propanol (0.6 mL). 
The reaction was chilled in an ice bath, and thionyl chloride (0.07 mL, 2 mmol, 2 
equiv.) was added dropwise. The reaction was allowed to ambiently warm to RT 
with stirring until judged complete by TLC. Once done, the brown solution was concentrated 
directly from this dram vial under vacuum to remove volatiles, and the crude product was carried 
forward with no further purification. For the purposes of the subsequent reaction, the yield was 
presumed to be quantitative. 
 
(±)-1-Benzyl 2-propyl azetidine-1,2-dicarboxylate. The crude (±)-propyl 
azetidine-2-carboxylate hydrochloride (89.9 mg, 0.5 mmol, 1 equiv.) 
synthesized above was suspended in methylene chloride (2.5 mL) and 
the dram vial was equipped with a stir bar, a septum, and a drying tube. 
The vial was chilled in an ice bath prior to the addition of triethylamine 
(0.35 mL, 2.5 mmol, 5 equiv.). Once addition was complete, benzyl 
chloroformate (0.14 mL, 1 mmol, 2 equiv.) was added dropwise. The reaction was allowed to 
warm to RT and stirring was continued until the reaction is judged complete by TLC analysis. 
Once complete, the reaction was transferred to a separatory funnel and quenched with 5 mL of 
saturated sodium bicarbonate solution. The layers were thoroughly mixed, and the aqueous layer 
was removed. The organic layer was washed with water (1x 5 mL) and brine (1x 5 mL) prior to 
drying over sodium sulfate. Once dry, the organics were decanted, and the volatiles were removed 
under vacuum. The crude product was purified by silica gel column chromatography (gradient 
from hexanes to 33% EtOAc in hexanes) to afford 25 mg (18% yield) of the titled compound a 
colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.40 – 7.27 (m, 5H), 5.17 – 5.04 (m, 2H), 4.69 (dd, J 
= 9.3, 5.2 Hz, 1H), 4.20 – 4.06 (m, 3H), 3.97 (ddd, J = 9.1, 8.1, 5.6 Hz, 1H), 2.57 (dtd, J = 11.5, 
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9.2, 6.3 Hz, 1H), 2.21 (ddt, J = 11.3, 8.9, 5.5 Hz, 1H), 1.64 (m, 2H – overlaps with HOD peak), 




(±)-Isopropyl azetidine-2-carboxylate hydrochloride. To an oven-dried 8-mL 
dram vial equipped with a stir bar, septum, and drying tube: (±)-azetidine-2-
carboxylic acid (50 mg, 1 mmol, 1 equiv.) was suspended in isopropanol (0.6 
mL). The reaction was chilled in an ice bath, and thionyl chloride (0.07 mL, 2 
mmol, 2 equiv.) was added dropwise. The reaction was allowed to ambiently 
warm to RT with stirring until judged complete by TLC. Once done, the brown solution was 
concentrated directly from this dram vial under vacuum to remove volatiles, and the crude product 
was carried forward with no further purification. For the purposes of the subsequent reaction, the 
yield was presumed to be quantitative. 
 
(±)-1-Benzyl 2-isopropyl azetidine-1,2-dicarboxylate. The crude (±)-
isopropyl azetidine-2-carboxylate hydrochloride (89.9 mg, 0.5 mmol, 1 
equiv.) synthesized above was suspended in methylene chloride (2.5 
mL) and the dram vial was equipped with a stir bar, a septum, and a 
drying tube. The vial was chilled in an ice bath prior to the addition of 
triethylamine (0.35 mL, 2.5 mmol, 5 equiv.). Once addition is complete, 
benzyl chloroformate (0.14 mL, 1 mmol, 2 equiv.) was added dropwise. The reaction was allowed 
to warm to RT and stirring was continued until the reaction was judged complete by TLC analysis. 
Once complete, the reaction was transferred to a separatory funnel and quenched with 5 mL of 
saturated sodium bicarbonate solution. The layers were thoroughly mixed, and the aqueous layer 
was removed. The organic layer was washed with water (1x 5 mL) and brine (1x 5 mL) prior to 
drying over sodium sulfate. Once dry, the organics were decanted, and the volatiles removed under 
vacuum. The crude product was purified by silica gel column chromatography (gradient from 
hexanes to 33% EtOAc in hexanes) to afford 65 mg (47% yield) of the titled compound a colorless 
oil. 1H NMR (400 MHz, CDCl3) δ 
1H NMR (400 MHz, CDCl3) δ 7.39 – 7.27 (m, 5H), 5.18 – 4.98 
(m, 3H), 4.64 (dd, J = 9.3, 5.2 Hz, 1H), 4.11 (m, 1H), 3.97 (m, 1H), 2.56 (dtd, J = 11.5, 9.2, 6.3 







(±)-Methyl azetidine-2-carboxylate hydrochloride. To an oven-dried 8-mL 
dram vial equipped with a stir bar, septum, and drying tube: (±)-azetidine-2-
carboxylic acid (100 mg, 1 mmol, 1 equiv.) was suspended in methanol (1.25 
mL). The reaction was chilled in an ice bath, and thionyl chloride (0.15 mL, 2 
mmol, 2 equiv.) was added dropwise. The reaction was allowed to ambiently 
warm to RT with stirring until judged complete by TLC. Once done, the solution was concentrated 
directly from this dram vial under vacuum to remove volatiles, and the crude product was carried 
forward with no further purification. For the purposes of the subsequent reaction, the yield was 
presumed to be quantitative. 
 
(±)-1-Benzyl 2-methyl azetidine-1,2-dicarboxylate. The crude methyl 
azetidine-2-carboxylate hydrochloride (151.59 mg, 1 mmol, 1 equiv.) 
synthesized above was suspended in methylene chloride (5 mL) and the 
dram vial was equipped with a stir bar, a septum, and a drying tube. The 
vial was chilled in an ice bath prior to the addition of triethylamine (0.69 
mL, 5 mmol, 5 equiv.). Once addition was complete, benzyl 
chloroformate (0.29 mL, 2 mmol, 2 equiv.) was added dropwise. The reaction was allowed to 
warm to RT and stirring was continued until the reaction was judged complete by TLC analysis. 
Once complete, the reaction was transferred to a separatory funnel and quenched with 5 mL of 
saturated sodium bicarbonate solution. The layers were thoroughly mixed, and the aqueous layer 
was removed. The organic layer was washed with water (1x 5 mL) and brine (1x 5 mL) prior to 
drying over sodium sulfate. Once dry, the organics were decanted, and the volatiles removed under 
vacuum. The crude product was purified by silica gel column chromatography (gradient from 
hexanes to 40% EtOAc in hexanes) to afford 123 mg (49% yield) of the titled compound a colorless 
oil. 1H NMR (400 MHz, CDCl3) δ 7.40 – 7.28 (m, 5H), 5.25 – 5.02 (m, 2H), 4.71 (dd, J = 9.3, 5.3 
Hz, 1H), 4.11 m, 1H), 3.98 (m, 1H), 3.76 (br s, 3H), 2.57 (dtd, J = 11.6, 9.2, 6.3 Hz, 1H), 2.23 
(ddt, J = 11.4, 9.0, 5.5 Hz, 1H). 
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Enzymatic Reactions & Product Characterization 
 




To a 250-mL screw-cap Erlenmeyer flask: 47.5 mL of E. coli whole cell suspension harboring 
P411-AzetS ([P411-AzetS] = 5.25 μM, final reaction concentration 5.0 μM, 0.25 μmol, 5·10–4 
equiv.) was added. The whole cell suspension ws degassed with nitrogen and put into an anerobic 
Coy chamber. Under inert atmosphere, 1.25 mL of an acetonitrile solution of the corresponding 
aziridine ([Aziridine] = 400 mM, final reaction concentration 10 mM, 0.5 mmol, 1 equiv.) and 
1.25 mL of an acetonitrile solution of the corresponding diazo compound ([Diazo] = 600 mM, 
final reaction concentration 15 mM, 0.75 mmol, 1 equiv.) were added in sequence. The vial was 
securely capped to exclude oxygen, the flask was removed from the anaerobic chamber, and the 
reaction was allowed to shake at RT until judged complete (ca. 4–16 hours). 
TTN and Analytical Yield Determination 
A 400 μL aliquot of the above reaction solution was mixed with 600 μL of a 1:1 solution of ethyl 
acetate:cyclohexane with 10 mM of the appropriate internal standard in a 1.7-mL Eppendorf tube. 
The layers were thoroughly mixed, and the phases were separated by centrifugation (14000 g, 10 
minutes, RT). Once separated, 100 μL of the organic layer was siphoned off and diluted in 900 μL 
of ethyl acetate. This solution was subjected to GC-FID analysis to determine the analytical yield 
and TTN of the reaction. 
 
Isolated Yield: 
Once complete, the reaction was split into two 25 mL aliquots across two 50 mL falcon tubes. The 
suspensions are extracted three times with ethyl acetate as follows: 25 mL of ethyl acetate were 
added to each tube and the phases were mixed by hand-shaking the tubes. Upon thorough mixing, 
the phases were separated by centrifugation (5000 g, 5 minutes, RT) and the organic phase was 
siphoned off. The combined organics were dried over sodium sulfate; once dry, the drying agent 
was decanted, and the volatiles removed under vacuum. The crude residue was purified by silica 
gel column chromatography to yield the titled compounds. 
 
Note About Stereochemical Assignments: 
The absolute stereochemistry for the model substrate 2 was determined by synthesis of the S-
enantiomer, which corresponds to the major product produced in the reaction. The stereochemistry 
of products 3-9 are assigned by analogy. 
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1-Benzyl 2-ethyl (S)-azetidine-1,2-dicarboxylate (2). Synthesized 
using the general procedure for preparative scale reactions starting with 
benzyl aziridine-1-carboxylate and ethyl diazoacetate as substrates. The 
product was purified by silica gel column chromatography (gradient 
from 100% hexanes to 40% EtOAc in hexanes) to afford the titled 
compound as a colorless oil. 
 
Value Run 1 Run 2 Average 
TTN (GC) 1560 1430 1490 
%Yield (GC) 78% 72% 75% 
Yield (Isolated) 91 mg (69%) 86 mg (65%) 67% 
er (GC) 99:1 99:1 --/-- 
 
1H NMR (400 MHz, CDCl3) δ 7.39 – 7.27 (m, 5H), 5.10 (m, 2H), 4.68 (dd, J = 9.3, 5.3 Hz, 1H), 
4.19 (br s, 2H), 4.12 (m, 1H), 3.97 (m, 1H), 2.57 (dtd, J = 11.5, 9.2, 6.3 Hz, 1H), 2.22 (ddt, J = 
11.3, 9.0, 5.5 Hz, 1H), 1.30 – 1.17 (br m, 3H).13C NMR (101 MHz, CDCl3) δ 171.12, 155.71, 
136.41, 128.41, 128.00, 127.88, 66.78, 61.28, 60.57, 47.68, 20.70, 14.08.
 
HRMS (FAB+) exact 
mass calculated for [M+H]+ (C14H18O4N) requires m/z 264.1236, found m/z 264.1249.
 
 
2-Ethyl 1-(thiophen-2-ylmethyl) (S)-azetidine-1,2-dicarboxylate (3). 
Synthesized using the general procedure for preparative scale reactions 
starting with thiophen-2-ylmethyl aziridine-1-carboxylate and ethyl 
diazoacetate as substrates. The product was purified by silica gel column 
chromatography (gradient from 100% hexanes to 20% EtOAc in 
hexanes) to afford the titled compound as a colorless oil. 
 
Value Run 1 Run 2 Average 
TTN (GC) 760 767 764 
%Yield (GC) 38.0% 38.3% 38% 
Yield (Isolated) 49.4 mg (37% yield) 51.4 mg (38% yield) 38% 
er (GC) 99:1 99:1 --/-- 
 
1H NMR (400 MHz, CDCl3) δ 7.29 (dd, J = 5.0, 1.3 Hz, 1H), 7.07 (d, J = 3.5 Hz, 1H), 6.96 (dd, J 
= 5.1, 3.5 Hz, 1H), 5.24 (m, 2H), 4.66 (dd, J = 9.4, 5.3 Hz, 1H), 4.20 (br s, 2H), 4.10 (m, 1H), 3.95 
(m, 1H), 2.56 (dtd, J = 11.5, 9.2, 6.3 Hz, 1H), 2.20 (ddt, J = 11.3, 9.0, 5.5 Hz, 1H), 1.24 (br s, 3H). 
13C NMR (101 MHz, CDCl3) δ 171.03, 155.41, 138.48, 127.82, 126.68, 126.61, 61.29, 61.19, 
60.57, 47.71, 20.70, 14.07. HRMS (ES+) exact mass calculated for [M+H]+ (C12H16NO4S) 




2-Ethyl 1-(4-fluorobenzyl) (S)-azetidine-1,2-dicarboxylate (4). 
Synthesized using the general procedure for preparative scale 
reactions starting with 4-fluorobenzyl aziridine-1-carboxylate and 
ethyl diazoacetate as substrates. The product was purified by silica 
gel column chromatography (gradient from 100% hexanes to 25% 
EtOAc in hexanes) to afford the titled compound as a colorless oil. 
 
Value Run 1 Run 2 Average 
TTN (GC) 613 640 626 
%Yield (GC) 30.6% 32.0% 31% 
Yield (Isolated) 41 mg (29% yield) 41 mg (29% yield) 29% 
er (GC) 99:1 99:1 --/-- 
 
1H NMR (400 MHz, CDCl3) δ 7.31 (dd, J = 8.4, 5.4 Hz, 2H), 7.02 (m, 2H), 5.06 (m, 2H), 4.67 
(dd, J = 9.3, 5.3 Hz, 1H), 4.19 (br s, 2H), 4.10 (m, 1H), 3.96 (m, 1H), 2.57 (dtd, J = 11.5, 9.2, 6.4 
Hz, 1H), 2.21 (ddt, J = 11.3, 9.0, 5.5 Hz, 1H), 1.30 – 1.18 (br s, 3H).
 13C NMR (101 MHz, CDCl3) 
δ 171.05, 162.52 (d, J = 246.4 Hz), 155.58, 132.26 (d, J = 3.3 Hz), 129.90 (d, J = 8.4 Hz), 115.31 
(d, J = 21.4 Hz), 66.07, 61.28, 60.37, 47.70, 20.69, 14.07.
 19F NMR (282 MHz, CDCl3) δ -114.28 
(br s).
 
HRMS (ES+) exact mass calculated for [M+H]+ (C14H17FNO4) requires m/z 282.1142, found 
m/z 282.1148. 
 
2-Ethyl 1-(3-fluorobenzyl) (S)-azetidine-1,2-dicarboxylate (5). 
Synthesized using the general procedure for preparative scale 
reactions using 3-fluorobenzyl aziridine-1-carboxylate and ethyl 
diazoacetate as substrates. The product was purified by silica gel 
column chromatography (gradient from 100% hexanes to 20% 
EtOAc in hexanes) to afford the titled compound as a colorless oil. 
 
Value Run 1 Run 2 Average 
TTN (GC) 650 712 681 
%Yield (GC) 33% 36% 34% 
Yield (Isolated) 41.7 mg (30% yield) 39.7 mg (29% yield) 29% 
er (GC) 99:1 99:1 --/-- 
 
1H NMR (400 MHz, CDCl3) δ 7.30 (td, J = 7.9, 5.8 Hz, 1H), 7.13 – 6.94 (m, 3H), 5.22 – 4.98 
(m, 2H), 4.70 (dd, J = 9.3, 5.3 Hz, 1H), 4.27 – 4.17 (m, 2H), 4.16 – 4.08 (m, 1H), 3.99 (ddd, J = 
9.1, 8.1, 5.6 Hz, 1H), 2.59 (dtd, J = 11.6, 9.2, 6.3 Hz, 1H), 2.23 (ddt, J = 11.4, 9.1, 5.5 Hz, 1H), 
1.30 – 1.18 (m, 3H). 13C NMR (101 MHz, CDCl3) δ 171.03, 162.79 (d, J = 246.1 Hz), 155.39, 
138.96 (d, J = 7.4 Hz), 129.95 (d, J = 8.2 Hz), 123.09, 114.82 (d, J = 21.1 Hz), 114.48 (d, J = 
22.0 Hz), 65.84, 61.35, 60.63, 47.59, 20.72, 14.06. 19F NMR (282 MHz, CDCl3) δ -113.22 (td, J 
S29 
= 10.1, 6.5 Hz). HRMS (ES+) exact mass calculated for [M+H]+ (C14H17FNO4) requires m/z 
282.1142, found m/z 282.1154. 
 
2-Ethyl 1-(2-fluorobenzyl) (S)-azetidine-1,2-dicarboxylate (6). 
Synthesized using the general procedure for preparative scale reactions 
using 2-fluorobenzyl aziridine-1-carboxylate and ethyl diazoacetate as 
substrates. The product was purified by silica gel column 
chromatography (gradient from 100% hexanes to 20% EtOAc in 
hexanes) to afford the titled compound as a colorless oil. 
 
Value Run 1 Run 2 Average 
TTN (GC) 826 796 811 
%Yield (GC) 41.3% 39.8% 41% 
Yield (Isolated) 50.5 mg (36% yield) 50.2 mg (36% yield) 36% 
er (GC) 99:1 99:1 --/-- 
 
1H NMR (400 MHz, CDCl3) δ 7.38 (m, 1H), 7.29 (m, 1H), 7.12 (m, 1H), 7.04 (m, 1H), 5.17 (q, J 
= 12.7 Hz, 2H), 4.68 (dd, J = 9.3, 5.3 Hz, 1H), 4.19 (m, 2H), 4.11 (td, J = 8.6, 6.3 Hz, 1H), 3.97 
(td, J = 8.6, 8.2, 5.7 Hz, 1H), 2.57 (dtd, J = 11.6, 9.2, 6.3 Hz, 1H), 2.21 (ddt, J = 11.3, 9.0, 5.5 Hz, 
1H), 1.24 (m, 3H). 13C NMR (101 MHz, CDCl3) δ 171.05, 160.81 (d, J = 248.3 Hz), 155.52, 
130.29, 129.90 (d, J = 8.1 Hz), 124.02 (d, J = 3.7 Hz), 123.56 (d, J = 14.4 Hz), 115.28 (d, J = 21.2 
Hz), 61.28, 60.76 (d, J = 4.4 Hz), 60.64 (br, obscured by doublet at 60.76), 47.70, 20.70, 14.05. 
19F NMR (282 MHz, CDCl3) δ -118.40 (m). HRMS (ES+) exact mass calculated for [M+H]
+ 
(C14H17FNO4) requires m/z 282.1142, found m/z 282.1114. 
 
1-Benzyl 2-propyl (S)-azetidine-1,2-dicarboxylate (7). Synthesized 
using the general procedure for preparative scale reactions using 
benzyl aziridine-1-carboxylate and propyl diazoacetate as substrates. 
The product is purified by silica gel column chromatography (gradient 
from 100% hexanes to 20% EtOAc in hexanes) to afford the titled 
compound as a colorless oil. 
 
Value Run 1 Run 2 Average 
TTN (GC) 314 411 363 
%Yield (GC) 16% 21% 18% 
Yield (Isolated) 19.6 mg (14% yield) 27.1 mg (20% yield) 17% 




1H NMR (400 MHz, CDCl3) δ 7.40 – 7.27 (m, 5H), 5.17 – 5.04 (m, 2H), 4.69 (dd, J = 9.3, 5.2 Hz, 
1H), 4.20 – 4.06 (m, 3H), 3.97 (ddd, J = 9.1, 8.1, 5.6 Hz, 1H), 2.57 (dtd, J = 11.5, 9.2, 6.3 Hz, 1H), 
2.21 (ddt, J = 11.3, 8.9, 5.5 Hz, 1H), 1.64 (m, 2H – overlaps with HOD peak), 0.91 (m, 3H). 13C 
NMR (101 MHz, CDCl3) 171.20, 155.70, 136.40, 128.40, 127.99, 127.89, 66.79, 66.78, 60.69, 
47.62, 21.86, 20.74, 10.22. HRMS (ES+) exact mass calculated for [M+H]+ (C15H20O4N) requires 
m/z 278.1392, found m/z 278.1400.
 
 
1-Benzyl 2-isopropyl (S)-azetidine-1,2-dicarboxylate (8). 
Synthesized using the general procedure for preparative scale reactions 
using benzyl aziridine-1-carboxylate and propyl diazoacetate as 
substrates. The product was purified by silica gel column 
chromatography (gradient from 100% hexanes to 20% EtOAc in 
hexanes) to afford the titled compound as a colorless oil. 
 
Value Run 1 Run 2 Average 
TTN (GC) 511 617 564 
%Yield (GC) 26% 31% 28% 
Yield (Isolated) 34.8 mg (25% yield) 41.5 mg (30% yield) 28% 
er (GC) >99:1 >99:1 --/-- 
 
1H NMR (400 MHz, CDCl3) δ 
1H NMR (400 MHz, CDCl3) δ 7.39 – 7.27 (m, 5H), 5.18 – 4.98 (m, 
3H), 4.64 (dd, J = 9.3, 5.2 Hz, 1H), 4.11 (m, 1H), 3.97 (m, 1H), 2.56 (dtd, J = 11.5, 9.2, 6.3 Hz, 
1H), 2.18 (ddt, J = 11.2, 9.0, 5.5 Hz, 1H), 1.22 (m, 6H). 13C NMR (101 MHz, CDCl3) δ 170.63, 
155.70, 136.41, 128.40, 127.97, 127.86, 68.84, 66.75, 60.85, 47.62, 21.65, 21.60, 20.68. HRMS 
(ES+) exact mass calculated for [M+H]+ (C15H20O4N) requires m/z 278.1392, found m/z 278.1367. 
 
1-Benzyl 2-methyl (S)-azetidine-1,2-dicarboxylate (9). Synthesized 
using the general procedure for preparative scale reactions starting with 
benzyl aziridine-1-carboxylate and methyl diazoacetate as substrates. 
The product was purified by silica gel column chromatography 
(gradient from 100% hexanes to 40% EtOAc in hexanes) to afford the 
titled compound as a colorless oil. 
 
Value Run 1 Run 2 Average 
TTN (GC) 405 399 402 
%Yield (GC) 20.2 20.0 20 
Yield (Isolated) 24 mg (19% yield) 21 mg (17% yield) 18% 
er (GC) 81:19 81:19  
 
S31 
1H NMR (400 MHz, CDCl3) δ 7.52 – 7.29 (m, 5H), 5.26 – 5.01 (m, 2H), 4.71 (dd, J = 9.1, 5.2 Hz, 
1H), 4.11 (m, 1H), 3.98 (m, 1H), 3.73 (br s, 3H), 2.57 (dtd, J = 11.3, 9.2, 6.4 Hz, 1H), 2.23 (ddt, J 
= 11.4, 8.9, 5.4 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 171.58, 155.73, 136.40, 128.43, 128.03, 
127.91, 66.82, 60.51, 52.27, 47.75, 20.69. HRMS (FAB+) exact mass calculated for [M+H]+ 





Procedure for 10-mmol Scale Reaction 
 
Starter Culture & Expression Culture: 
A single colony of E. coli harboring plasmids encoding P411-AzetS was used to inoculate 200 mL 
of LB-amp. The culture was allowed to incubate overnight at 37 °C, shaking at 240 RPM.  
 
The following day: six expression cultures (1L) were inoculated with 20 mL of the above overnight 
culture. The expression cultures were incubated at 37 °C, shaking at 240 RPM, for 2.5 hours and 
the OD600 is measured to be 1.0. At this point, the six expression cultures were held on ice for 30 
minutes wherein 1 mL of 1000x stocks of ALA and IPTG are added such that the final 
concentrations were 1.0 mM of ALA and 0.5 mM of IPTG, respectively. The cultures were allowed 
to incubate for 20 hours at 22 °C, shaking at 140 RPM. 
 
Preparation of Clarified Lysate for Protein Concentration Determination: 
 
The expression cultures were pelleted by centrifugation (5000 g, 5 minutes, 4 °C). The cell pellets 
were pumped into the anaerobic Coy chamber, wherein they were resuspended in 300 mL of 
rigorously degassed M9-N buffer adjusted to pH = 7.0 and combined in a screw-top Erlenmeyer. 
For protein concentration determination, 3 mL of the whole cell suspension were siphoned off, 
diluted in 3 mL of additional M9-N, and the protein concentration was measured as described in 
the “General Information and Procedures” section of the SI. The Erlenmeyer with the whole cell 
suspension was capped with an air-tight cap and was held on ice until the protein concentration 








Safety Note: 15 mmol of ethyl diazoacetate can be expected to liberate 15 mmol of N2, or 336 mL 
of N2. Use of a flask with excess headspace prevents overpressurization of the reaction vessel in 
this reaction.  
 
Once the protein concentration was determined, the whole cell suspension was diluted in a 2.0 L 
screw-top Erlenmeyer flask in the anaerobic Coy chamber with rigorously degassed M9-N buffer 
adjusted to pH = 7.0 such that 950 mL of whole cell suspension has a protein concentration of 5.25 
μM (final reaction concentration 5.0 μM, 5 μmol, 5·10–4 equiv.). For this experiment, the OD600 
was measured to be approximately 30. Once ready, 24 mL of a 417 mM solution of benzyl 
S33 
aziridine-1-carboxylate in MeCN (final reaction concentration, 10 mM, 10 mmol, 1.77 g, 1 equiv.) 
was added with agitation, followed by addition of 24 mL of a 625 mM solution of ethyl 
diazoacetate (final reaction concentration 15 mM, 1.71 g, 1.5 equiv.) with heavy agitation. The 
flask was tightly capped to exclude oxygen, pumped out of the anaerobic chamber, and was 
allowed to shake at 220 RPM until judged complete. 
 
Workup and Isolation: 
Once complete, three 400-μL aliquots were removed and used to determine the reaction TTN and 
yield by gas chromatography (1220 TTN, 61% yield). For preparative isolation, the reaction 
mixture was split into 2x 500 mL portions. Each portion was mixed with 500 mL of EtOAc; the 
layers were thoroughly mixed before the organic layer was siphoned off (the layers may be 
separated by centrifugation, if necessary, at 5000 g for 5 minutes at RT). The combined organics 
were dried over sodium sulfate; once dried, the supernatant was decanted from the drying agent 
and the volatiles removed under vacuum. The crude product was purified by silica gel column 
chromatography (gradient from 100% hexanes to 30% EtOAc in hexanes) to afford 1.44 g (55% 
isolated yield) of the titled compound as a colorless oil with 99:1 er. Characterization data was 




Chiral Traces for Determination of Enantiopurity: 
Preparative-Scale Reactions 
 
The enantiopurity of all products was determined by gas chromatography using CP-Chirasil-Dex 
CB (Agilent) as a chiral stationary phase. All products could be separated using the same GC 
conditions, which are as follows: start at 50 °C, ramp at 10 °C/minute to 170 °C and hold for 38 
minutes. Ramp at 30 °C/minute to 200 °C and hold for 9 minutes. 
 
 




















































































































Chiral Traces for Determination of Enantiopurity: 
Evolutionary Lineage 
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